Datuk Dr. Doris Wong Sing Ee - 26 Feb 2025 SCHEDULE 13D Report for Cyclacel Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (CYCC)

Filing Manager
Datuk Dr. Doris Wong Sing Ee
Reporting Manager
Doris Wong Sing Ee
Security
Cyclacel Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share
Symbol
CYCC
Shares outstanding
278,041,171 shares
Disclosed Ownership
194,628,820 shares
Ownership
70%
Form type
SCHEDULE 13D
Filing time
04 Mar 2025, 10:32:06 UTC
Date of event
26 Feb 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Datuk Dr. Doris Wong Sing Ee disclosed 70% ownership in Cyclacel Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (CYCC) on 26 Feb 2025."

Quick Takeaways

  • Datuk Dr. Doris Wong Sing Ee filed SCHEDULE 13D for Cyclacel Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (CYCC).
  • Disclosed ownership: 70%.
  • Date of event: 26 Feb 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 04 Mar 2025, 10:32.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Doris Wong Sing Ee 70% 194,628,820 194,628,820 0 /s/ Datuk Dr. Doris Wong Sing Ee Chief Executive Officer 0001892421

Sponsored